(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. Activation of XNF-ATc3 generates neural CE defects and anterior
truncations. (A) Xenopus embryos were injected at the
one-cell stage with 100 pg (middle panels) or 500 pg (right panels) of CA
XNF-ATc3. Embryos injected with 100 pg CA XNF-ATc3 resembled
control embryos during gastrula stages (first row, vegetal view of stage 11;
second row, vegetal view of stage 12.5), but developed neural tube CE defects
in 31% of embryos at neurula stages (third row: dorsal view of stage 17).
Embryos injected with 500 pg CA XNF-ATc3 exhibited slight defects at
stage 12.5 and neural CE defects in 81% of injected embryos. Control embryos
developed no neural CE defects. (B) Xenopus embryos were
injected at the one-cell stage with 50 pg CA XNF-ATc3 and analyzed
for Krox20, Eng, Pax3, Sox2 and HoxB9 expression at the
neurula stage. For XAG-1 in situ hybridization embryos were injected
with 250 pg CA XNF-ATc3 and 100 pg lacZ (red) for lineage
tracing.